Exelixis (EXEL)
59.01
-0.12 (0.20%)
Upcoming Events
Latest Headlines
BMO Capital Starts Exelixis (EXEL) at Market Perform
August 18, 2026 4:13 PM - StreetInsider
Form SCHEDULE 13D/A EXELIXIS, INC. Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.
August 14, 2026 8:21 AM - SEC Filing
Form 4 EXELIXIS, INC. For: Aug 10 Filed by: Beckerle Mary C
August 12, 2026 7:34 PM - SEC Filing
Form SCHEDULE 13G/A EXELIXIS, INC. Filed by: AQR CAPITAL MANAGEMENT LLC
August 12, 2026 7:18 AM - SEC Filing
Form 144 EXELIXIS, INC. Filed by: Beckerle Mary C
August 10, 2026 4:15 PM - SEC Filing
Leerink Downgrades Exelixis (EXEL) to Market Perform
August 6, 2026 1:38 PM - StreetInsider
Exelixis (EXEL) PT Raised to $51 at Stifel
August 6, 2026 8:09 AM - StreetInsider
Exelixis (EXEL) PT Lowered to $52 at Truist Securities
August 6, 2026 7:22 AM - StreetInsider
Exelixis (EXEL) PT Raised to $50 at Wells Fargo
August 6, 2026 6:38 AM - StreetInsider
Form S-8 EXELIXIS, INC.
August 5, 2026 4:29 PM - SEC Filing
Form 10-Q EXELIXIS, INC. For: Jul 03
August 5, 2026 4:18 PM - SEC Filing
Form 8-K EXELIXIS, INC. For: Aug 05
August 5, 2026 4:13 PM - SEC Filing
Exelixis (EXEL) Tops Q2 EPS by 7c ; Offers Guidance
August 5, 2026 4:10 PM - StreetInsider
Exelixis Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 5, 2026 4:05 PM - BizWire
Exelixis (EXEL) Reiterated at Market Outperform by Citizens Amid Handa Patent Suit
August 3, 2026 4:27 AM - StreetInsider
Exelixis (EXEL) Reiterated at Market Outperform by Citizens Amid Handa Patent Suit
August 3, 2026 4:22 AM - StreetInsider
Exelixis (EXEL) PT Raised to $53 at Morgan Stanley
July 23, 2026 8:43 AM - StreetInsider
Exelixis to Release Second Quarter 2026 Financial Results on Wednesday, August 5, 2026
July 22, 2026 4:30 PM - BizWire
Exelixis (EXEL) Reiterated at Market Outperform by Citizens on Positive Q2 Script Growth
July 22, 2026 4:15 AM - StreetInsider
Exelixis (EXEL) PT Raised to $49 at Barclays
July 14, 2026 5:12 AM - StreetInsider
Exelixis (EXEL) PT Raised to $49 at Wells Fargo
July 13, 2026 6:28 AM - StreetInsider
Exelixis (EXEL) PT Raised to $49 at Wells Fargo
July 13, 2026 6:28 AM - StreetInsider
Exelixis (EXEL) PT Raised to $46 at RBC Capital
July 7, 2026 8:00 AM - StreetInsider
Exelixis (EXEL) PT Raised to $56 at Truist Securities
July 7, 2026 7:09 AM - StreetInsider
Exelixis (EXEL) PT Raised to $52 at UBS on Upcoming Catalysts
July 2, 2026 8:31 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Exelixis (EXEL)
July 2, 2026 6:42 AM - StreetInsider
Truist Securities Assumes Exelixis (EXEL) at Hold
June 25, 2026 6:13 AM - StreetInsider
Exelixis (EXEL) Reiterated at Market Outperform by Citizens on Q2 Cabo Script Growth
June 24, 2026 4:09 AM - StreetInsider
Morgan Stanley on Exelixis (EXEL): today's update 'mixed-to-negative at the margin'
June 22, 2026 12:29 PM - StreetInsider
Exelixis colorectal cancer trial misses one of two survival goals
June 22, 2026 8:01 AM - StreetInsider
Exelixis Provides Update on the Phase 3 STELLAR-303 Trial Evaluating Zanzalintinib in Combination with an Immune Checkpoint Inhibitor in Patients with Metastatic Colorectal Cancer
June 22, 2026 8:00 AM - BizWire
Full Article List
